Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The impact of fat intake on hypercholesterolemia and related atherosclerotic cardiovascular diseases has been studied for decades. However, the current evidence base suggests that fatty acids also influences cardiometabolic diseases through other mechanisms including effects on glucose metabolism, body fat distribution, blood pressure, inflammation, and heart rate. Furthermore, studies evaluating single fatty acids have challenged the simplistic view of shared health effects within fatty acid groups categorized by degree of saturation. In addition, investigations of endogenous fatty acid metabolism, including genetic studies of fatty acid metabolizing enzymes, and the identification of novel metabolically derived fatty acids have further increased the complexity of fatty acids’ health impacts. This Special Issue aims to include original research and up-to-date reviews on genetic and dietary modulation of fatty acids, and the role and function of dietary and metabolically derived fatty acids in cardiometabolic health.

omega-3 --- cardiovascular disease --- statins --- type 2 diabetes mellitus --- medium-chain triglyceride --- long-chain triglyceride --- lipid metabolism --- klotho --- CKD --- fish oil --- fibrosis --- inflammation --- cardiometabolic disease --- unsaturated fat --- Mediterranean diet --- low-fat diet --- alternatively activated macrophages --- perivascular adipose tissue --- type 2 cytokines --- erucic acid --- fish --- seafood --- furan fatty acids --- docosapentaenoic acid --- conjugated fatty acids --- cardiovascular disease --- metabolic disease --- blood lipids --- inflammation --- antioxidant --- CYP450 eicosanoids --- omega-3 PUFA --- omega-6 PUFA --- blood pressure --- hemodynamics --- children --- EETs --- EEQs --- fatty acid --- diet --- genotype --- human --- FADS --- fatty acid --- desaturase --- Genome-wide association study (GWAS) --- Insulin sensitivity --- adipose tissue --- cholesterol ester --- omega 3 --- PUFA --- n-3 PUFA --- COPD --- inflammation --- coronary artery disease --- ischemic heart disease --- CAD --- CHD --- fat --- obesity --- body weight --- cohort study --- substitution models --- epidemiology --- prospective cohort study --- n-6 fatty acids --- n-3 fatty acids --- linoleic acid --- arachidonic acid

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic inflammation, heart and liver diseases, diabetes, neurodegenerative diseases, etc. Although such health benefits have not been consistently observed in some intervention trials, positive results from clinical trials have provided direct evidence supporting the cancer-protective effect of green tea. In addition, numerous mechanisms of action have been suggested to contribute to tea’s disease-preventive effects. Furthermore, effects of the processing and storage of tea, as well as additives on tea’s properties have been investigated.

Camellia sinensis --- epigallocatechin gallate (EGCG) --- theanine --- caffeine --- Alzheimer’s disease --- Parkinson’s disease --- EGCG --- 6-OH-11-O-hydroxyphenanthrene --- neuroblastoma --- BE(2)-C --- N-MYC --- neuro-sphere --- polyphenol --- Liubao tea --- hepatic damage --- mRNA expression --- protein expression --- adrenal hypertrophy --- anxiety --- caffeine --- catechin --- green tea --- matcha --- salivary ?-amylase activity --- stress-reduction --- theanine --- tea consumption --- fracture --- cohort study --- ERCC1/XPF --- cisplatin --- DNA repair --- chemoresistance --- green tea polyphenols --- kudingcha --- yerba mate --- yaupon holly --- guayusa --- caffeine --- polyphenols --- tea --- polyphenols --- bioaccessibility --- nutraceutical --- microbiota --- Rosmarinic acid --- suberoylanilide hydroxamic acid (SAHA) --- histone deacetylase 2 (HDAC2) --- p53 --- cell cycle arrest and apoptosis --- green tea catechins --- epigallocatechin-gallate (EGCG) --- 67LR --- cancer apoptosis --- cell death --- chemoprevention --- gene expression --- cancer --- EGCG --- diseases --- green tea --- tea polyphenols --- anti-oxidant --- anti-photoaging --- heme oxygenase-1 --- nuclear factor erythroid 2-related factor 2 (Nrf2) --- matrix metalloproteinase-1 (MMP-1) --- green tea --- oxalate --- renal stone --- calcium oxalate monohydrate --- hypercalciuria --- n/a